- Patent Title: MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same
-
Application No.: US16795391Application Date: 2020-02-19
-
Publication No.: US11618770B2Publication Date: 2023-04-04
- Inventor: Tomoya Miyakawa , Masaaki Oka , Shoichi Hazama , Koji Tamada , Keiko Udaka
- Applicant: NEC CORPORATION
- Applicant Address: JP Tokyo
- Assignee: NEC CORPORATION
- Current Assignee: NEC CORPORATION
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2015-046462 20150309
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K7/06 ; C12N5/10 ; A61K38/00 ; C07K14/47 ; C07K14/705
Abstract:
The present invention provides a peptide that includes eight or more consecutive amino acid residues of amino acid sequence of one of Sequence ID Nos. 1 to 12 and that consists of eleven or less amino acid residues.
Public/Granted literature
Information query
